Back to CVE records
High 8.3Published Jun 24, 2025

CVE-2025-6032Podman: podman missing tls verification

Updated under an hour ago ()

Does this affect you?

It affects Red Hat Enterprise Linux 10 and 2 other products. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A flaw was found in Podman. The podman machine init command fails to verify the TLS certificate when downloading the VM images from an OCI registry. This issue results in a Man In The Middle attack.

CVSS
8.3 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:C/C:H/I:H/A:H
Weakness (CWE)
CWE-295
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
redhat
NVD analysis
Deferred
Record last updated
Oct 12, 2026
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
from 6:5.4.0-12.el10_0 not affected
CNA record
from 4:4.9.4-18.el9_4.2 not affected
CNA record
from 4:4.9.4-14.rhaos4.16.el8 not affected
CNA record

References

  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vendor-advisory, x-refsource-redhat
  • vdb-entry, x-refsource-redhat
  • issue-tracking, x-refsource-redhat

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.